Table 1.
No | Risk factor | Details | Regions | References |
---|---|---|---|---|
1 | HBV | Inactivates tumor-suppressing genes | Africa, People’s Republic of China | 1–3, 6 |
2 | HCV | Immune response-mediated direct infection that leads to cirrhosis | USA, UK | 1–3, 6 |
3 | AFB1 | Contamination of staple foods by fungi Aspergillus flavus and Aspergillus parasiticus | Sub-Saharan Africa, Eastern Asia | 1, 2, 8 |
4 | Hemochomatosis | Leakage of stored iron to hepatocytes in iron excess more than 5 g | Africa | 1, 2 |
5 | HIV | Chronic viral hepatitis | USA | 1, 3, 6–9 |
6 | Metabolic syndromes (obesity, diabetes, fatty liver disease) | Increased waist circumstances, particularly BMI more than 30 kg/m2 | USA | 1–3, 6, 7, 10 |
7 | Tobacco smoking | Smoking cumulatively 11,000 packs of cigarette during the lifetime increases the risk by 1.7-fold | USA | 1, 2, 7, 10 |
8 | Alcohol abuse | Excess of 80 g per day more than 10 years increases risk fivefold | USA, Europe | 1, 7, 10 |
9 | Mutation in germline DNA | Genetic predisposition to SNPs in EGF | USA | 2 |
10 | MOIVC | Obstruction of hepatic venous drainage by complete-clogged lesion | Africa | 2 |
11 | Oral contraception | Hepatocarcinogenic properties of oral contraception | USA | 2 |
Abbreviations: HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus; AFB1, aflatoxin B1 exposure; SNPs, single nucleotide polymorphisms; EGF, epidermal growth factor; MOIVC, membranous obstruction of the inferior vena cava; BMI, body mass index.